1. Home
  2. GRPN vs SLDB Comparison

GRPN vs SLDB Comparison

Compare GRPN & SLDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Groupon Inc.

GRPN

Groupon Inc.

HOLD

Current Price

$21.36

Market Cap

1.1B

ML Signal

HOLD

Logo Solid Biosciences Inc.

SLDB

Solid Biosciences Inc.

HOLD

Current Price

$9.29

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRPN
SLDB
Founded
2008
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Advertising
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
2011
2017

Fundamental Metrics

Financial Performance
Metric
GRPN
SLDB
Price
$21.36
$9.29
Analyst Decision
Hold
Strong Buy
Analyst Count
3
11
Target Price
$33.67
$16.36
AVG Volume (30 Days)
1.6M
957.2K
Earning Date
05-07-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
34.97
EPS
N/A
N/A
Revenue
$2,843,877,000.00
$8,094,000.00
Revenue This Year
$5.55
N/A
Revenue Next Year
$6.63
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.17
$3.79
52 Week High
$29.90
$11.45

Technical Indicators

Market Signals
Indicator
GRPN
SLDB
Relative Strength Index (RSI) 36.07 58.39
Support Level $15.97 $6.25
Resistance Level $22.39 $11.45
Average True Range (ATR) 1.68 0.44
MACD -0.89 0.10
Stochastic Oscillator 2.39 96.27

Price Performance

Historical Comparison
GRPN
SLDB

About GRPN Groupon Inc.

Groupon Inc is a globalised, scaled two-sided marketplace that connects consumers to merchants. Its categories include Local: local inventory includes things to do, beauty and wellness, food and drink, home and automotive services, online services, as well as other types of experiences and services. Goods: Includes merchandise across multiple product lines, such as electronics, sporting goods, jewelry, toys, household items and apparel, and Travel: Features travel experiences at both discounted and market rates, including hotels, airfare, and package deals covering both domestic and international travel. The company operates in two segments, North America and International, with the majority of revenue from the Local category from the North America Segment.

About SLDB Solid Biosciences Inc.

Solid Biosciences Inc is a life sciences company focused on advancing a portfolio of current and future gene therapy candidates, including SGT-003 for the treatment of Duchenne muscular dystrophy, SGT-212 for the treatment of Friedreich's ataxia, SGT-501 for the treatment of catecholaminergic polymorphic ventricular tachycardia, SGT-601 for the treatment of TNNT2-mediated dilated cardiomyopathy, and additional assets for the treatment of genetic cardiac and neuromuscular diseases. The majority of its current programs are designed to treat these diseases with gene transfer products. The company operates in a single segment, developing treatments through gene therapy and other means for patients with neuromuscular and cardiac diseases.

Share on Social Networks: